Table 1 List of the chemical compound.
From: Development of a novel anti-hepatitis B virus agent via Sp1
Code.No | Name of substrate | MW/compositional formula | |
|---|---|---|---|
AGI1 | Acarbose | 660.1/C25H43NO18 | |
AGI2 | Miglitol | 207.2/C8H17NO5 | |
AGI3 | Voglibose | 267.3/C10H21NO7 | |
Name of substrate/AKOS No/Ranking No. | MW/compositional formula/FPAS score | Structural formula | |
AGI4 | 2,6-dimethyl-1-[2-(oxolan-2-ylmethoxy)ethyl]piperidine/AKOS016935375/231 | 242.3/C15H30NO/531.5 |
|
AGI5 | 1-(4-methylpiperidin-1-yl)-3-naphthalen-2-yloxypropan-2-ol/AKOS016182856/236 | 300.4/C16H34N2O/610.3 |
|
AGI6 | 1-(2,6-dimethylpiperidin-1-yl)-3-(3-methoxyphenoxy)propan-2-ol/AKOS016050483/154 | 326.5/ C14H28NO2/586.1 |
|
AGI7 | 1-(4-tert-butylcyclohexyl)oxy-3-(2,6-dimethylpiperidin-1-yl)propan-2-ol/AKOS016286797/142 | 326.5/ C17H28NO3/586.1 |
|
AGI8 | 1-(1-adamantylmethoxy)-3-(3,5-dimethylpiperidin-1-yl)propan-2-ol/AKOS016318436/172 | 336.5/C16H34N2O/554.0 |
|
AGI9 | 2-(1,3-dioxolan-2-yl)-1-(2-methoxyethyl)piperidine/AKOS007774093/123 | 216.3/C14H25N2O/528.8 |
|
AGI10 | 3-[2-(1,3-dioxolan-2-yl)piperidin-1-yl]propan-1-ol/AKOS007869050/131 | 216.3/C15H30NO3/481.3 |
|
AGI11 | 1-methoxy-3-[4-(4-methylcyclohexyl)piperazin-1-yl]propan-2-ol/AKOS016924865/33 | 272.4/C15H24NO3/511.7 |
|
AGI12 | [2-[[1-(2,2-difluoroethyl)piperidin-4-yl] amino]cycloheptyl]methanol/AKOS016984232/8 | 292.4/C14H30N2O/539.4 |
|
AGI13 | 1-[3-(2-chlorophenoxy)-2-hydroxypropyl]-2,2,6,6-tetramethylpiperidin-4-ol/AKOS016128493/13 | 342.9/C15H30F2N2O/531.6 |
|
AGI14 | 1-[3-(4-tert-butylcyclohexyl)oxy-2-hydroxypropyl]-2,2,6,6-tetramethylpiperidin-4-ol/AKOS016287378/5 | 370.6/C14H28NO4/543.4 |
|
AGI15 | 1-[2-hydroxy-3-(3,3,5-trimethylcyclohexyl)oxypropyl]-2,2,6,6-tetramethylpiperidin-4-ol/AKOS016287379/6 | 356.6/ C15H32N2O2/542.1 |
|
